Charles Mizrahi and the team at Banyan Hill Publishing are out with a new presentation for presentation for Alpha Investor research featuring Charles Mizrahi No. 1 Genomics Stock Pick.
How to Boost Your Income by AT LEAST $36,000 Over the Next 12 Months
What Is Charles Mizrahi Genomics Stock Pick?
Take a look at this device:
This emerging tech is set to grow a projected 6,500% by 2025.
What’s more, it’s not artificial intelligence, crypto or some sort of Silicon Valley hardware/software.
What’s the tech inside this device?
McKinsey projects this will create $40 trillion in market value over the next decade.
Forbes believes this tech will mint the world’s first trillionaire.
A handful of billionaires are each pouring $100 million into this space every year to fund projects.
And you know what’s crazy?
This tech is changing lives already … right now.
And over 2 billion people could be affected in three years!
What is it?
This is a handheld DNA sequencer.
You put a drop of saliva or blood in here … you plug it into the computer … and in a few hours, you can see your genetic code on the screen.
As you can see… This device fits in the palm of my hand…
But why is this important to you?
If you’re looking for massive returns this coming decade to grow your wealth … as someone who’s looking for the next big investment…
Well…
Right now — only 30 million people have had their DNA sequenced…
In one 2015 study from the University of Illinois, scientists project that number could get as high as 2 billion … by 2025.
That’s potentially 6,500% growth … in three years.
And it’s only going to keep growing by leaps and bounds the rest of this decade.
It’s because of how fast this technology’s price has fallen … because of tech like this device I hold here in my hands … that’s going to accelerate this growth.
And according to Charles Mizrahi, this technology is going to be the fastest growing sector this decade.
— RECOMMENDED —
A New Way To See Which Stocks Could Double Your Money
We want to give you FREE access to the Power Gauge system ($5,000 value).
Claim FREE access to The Power Gauge Here
How To Invest in Charles Mizrahi Genomics Stock Pick?
Genomics is on track to become a huge mega trend over the next 10 years.
Charles Mizrahi’s brand new report “The $40 Trillion Genomics Industry” gives you all the details on the one company he expects to leverage this tech’s incredible 6,500% growth by 2025. You can access this report for free by subscribing to his Alpha Investor service.
As you saw in the video…
- Genomics technology isn’t some far-off future promise — 30 million people have already had their DNA sequenced with this technology…
- As the cost of genetic sequencing continues to drop, up to an estimated 2 billion people will take advantage of this life-saving technology in the next three years alone…
- The growth of genomics tech over the next 10 years is a nearly unfathomable $40 trillion…
And artificial intelligence will be the “secret sauce” to help speed up the genomics mega trend.
Remember, something similar happened in the electric vehicle space.
Tesla sold just 937 cars in 2009. Today there are over one million Teslas on the road.
That’s exponential growth. And we’re going to see something very similar happen in the genomics space.
That’s why Charles Mizrahi wants you to grab your copy of his report TODAY.
He wants to help you succeed financially and build your wealth. Charles Mizrahi believes his Alpha Investor research can do that.
Once you subscribe, review your copy of The $40 Trillion Genomics Industry right away.
And if you’re an investor, take advantage of this opportunity the next morning as soon as the stock market opens.
What Is Alpha Investor?
Alpha Investor gives you access to Charles Mizrahi’s groundbreaking way of investing — an approach that’s accessible to everyone, regardless of how much money you have, your investment acumen or your risk tolerance.
Together, you’re going to get in on amazing companies that are flying under Wall Street’s radar, riding your shares to stunning gains. These are the types of lucrative companies that most investors don’t recognize until it’s far too late.
For example, using his system, Charles Mizrahi uncovered retailer TJX Companies. Wall Street had thrown away the stock in the belief that Amazon would crush it. Charles Mizrahi invested in 2010 and rode the shares to a 416% gain over the next several years.
Charles Mizrahi was also bullish on Microsoft at a time when many turned their noses up at it. CNN Money said their stock was in a “decade-long funk,” and Wall Street saw “a blue screen of death in their future.” But Charles Mizrahi knew better. And if you followed his lead, you would’ve rewarded yourself with a profit of over 400% by now.
With your subscription to Alpha Investor, you become a part of Charles Mizrahi’s inner circle where you can benefit from his 35 years of experience.
— RECOMMENDED —
GOLD ALERT: Extraordinary Upside in ONE Stock (Not a Miner)
Gold prices just surged to the highest level in a year and could be on the verge of the biggest bull run in half a century. (It gained 1,700% during the high-inflation 1970s.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees 1,500% potential gains long term with very little risk.
Who Is Charles Mizrahi?
Charles began his career on the trading floor of the New York Futures Exchange at the age of 20.
He spent almost 40 years on Wall Street, during which time he was featured in Barron’s, The New York Times, The Wall Street Journal … and was crowned the top market timer over a seven-year period.
He called the 1987 Black Monday crash, moving his clients’ assets out of stocks and into money market funds two weeks prior. He also called the dot-com crash and the 2008 financial crisis.
In each instance, people who heeded his warnings avoided catastrophic losses. For the past four years, he’s been helping Main Street investors make more money than they ever dreamed possible with his Alpha Investor research service.
What’s Included with Your Alpha Investor Subscription?
Here’s everything that you’ll get:
The $40 Trillion Genomics Industry
Inside this report is Charles Mizrahi’s No. 1 genomics stock pick, which will give you the best chance at riding the projected 6,500% exponential growth in the biotech market by 2025.
What’s more — you’ll get all his future research, recommendations and updates as a subscriber of Alpha Investor.
This means, you’ll also get Charles Mizrahi’s in-depth analysis of all the megatrends happening this decade: artificial intelligence, battery technology, fintech, 5G, and of course … genomic breakthroughs.
In addition to Charles Mizrahi’s report The $40 Trillion Genomics Industry…
You’ll also receive…
Alpha Investor Twelve Monthly Research Briefings
This is the core of Charles Mizrahi’s research service. You’ll get these reports in your inbox every month … each one containing a NEW stock pick for you to consider.
But Charles Mizrahi doesn’t just tell you what to invest in. He also explains why the company is such a smart buy. You don’t have to research a thing yourself. You hardly have to lift a finger. He lays it all out for you in black and white.
Alpha Investor Model Portfolio
These are the stocks Charles Mizrahi recommends buying — all listed out for you in one place.
All you have to do is read Charles Mizrahi’s research on the company and decide if it’s the right investment for you.
Weekly Updates
You’re going to hear from Charles every week in his video updates. Think of it as a fireside stock chat. He gives you a rundown on how the stocks in the portfolio are performing.
You’ll also get special alerts from him when it’s the best time to buy or sell … so you never have to worry about missing out on a big payday either.
The Alpha Investor Trading Manual
This report shows you exactly what to expect from Charles Mizrahi … and exactly what to do when you receive one of his stock recommendations. You’ll be able to hit the ground running the very first day you become an Alpha Investor.
Access To A Private Members-Only Website
This puts all your research briefings, special reports, and the model portfolio at your fingertips…
A Dedicated Customer Care Team
If you ever have any questions about your subscription … or if you need guidance on using any of the resources … just give Charles Mizrahi’s Customer Care team a call or send them an email. They’ll help with whatever you need.
Alpha Investor Pricing
You can Join Alpha Investor for just $47.
Alpha Investor Refund Policy
You’re covered by 100% money-back guarantee.
You can cancel your membership in Alpha Investor at any time — even on day 364 of your one-year subscription. All it takes is one phone call to Charles Mizrahi”s customer care team, and you’ll receive a prompt refund.
— RECOMMENDED —
DON’T Pay $35,000-Plus for Bitcoin
(Do THIS Instead)
Bottom Line: Should You Join?
The time to invest in megatrends is before everyone else jumps in
Charles Mizrahi has been spotting opportunities like these … ones that Wall Street talking heads seem to miss … for almost four decades now.
He pulled his clients’ money out in ’87 … warned folks of the dot-com crash … called the ’08 housing crisis … told investors to avoid bitcoin three months before the 2017 crash.
I doesn’t have a crystal ball. Charles Mizrahi just sees the signs that make a megatrend…
Like when cloud computing reached a critical point and he recommended Microsoft … now a 1,400% gain…
Or during the smartphone wars, he told his readers to get in on Apple … now an 839% gain…
And recently, as artificial intelligence heats up, Charles Mizrahi’s stock pick in II-VI Inc. is up over 80% already.
Seeing megatrends is how he managed to post 113% returns in a single year … and 313% returns over a three-year period for his former hedge fund…
In other words…
You’re about to leverage Charles Mizrahi’s 40 years of Wall Street experience to help you build your financial future.
When you get your copy of The $40 Trillion Genomics Industry … you’re not just getting a stock pick, you’re getting research that will make sense and give you peace of mind when you invest.
